Grifols S.A.

(GRFS) Trade

By |

Profile

As a vertically integrated plasma derivative producer, Spain-based Grifols collects plasma and then manufactures and sells plasma-derived products globally. By acquiring Talecris in 2011, Grifols dramatically expanded its plasma-derived product portfolio, and the firm's bioscience business contributed 79% of sales in 2017. Grifols also has smaller segments including diagnostics, hospital supplies, and biosupplies. Diagnostics grew to almost 20% of revenue in 2014 with the acquisition of Novartis' diagnostics unit.

Contact Information

Website: www.grifols.com
Email: inversores@grifols.com
Main Phone: +34 935710500
Address: Avinguda de la Generalitat, 152-158
Address 2: Parque empresarial Can Sant Joan
City / Town: Barcelona
Country: ESP
Postal Code: 08174

Issuer Information

Exchange: NGS
CEO: Raimon Grifols Roura / Víctor Grifols Deu
Employees: 18296
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 19.23 $ 0.41 (2.18%)
Last Price 19.23 Change $ 0.41 Change % 2.18 Tick N/A
Bid 19.27 Bid Size 400.00 Ask 19.36 Ask Size 200.00
Open 19.22 High 19.53 Low 19.15 Prev Close 18.82
Last Trade Volume 1.4 mi 52 Wk Hi 25.18 52 Wk Low 17.47
Market Cap 13.1 bi Ex-Div Date Div Rate 0.35 Yield 1.8160
Shares 683,737,763.00 EPS (TTM) 1.24 PE Ratio 15.30 Exchange NGS
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 26.5 26.5 26.5 26.5
Low Target Price Estimate 22 22 22 22
Mean Target Price Estimate 24.25 24.25 24.25 24.25
Standard Deviation 3.18 3.18 3.18 3.18
Date of Most Recent Estimate 05/04/18 05/04/18 05/04/18 06/11/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 4 2 2 2
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 1 1 1 1
Strong Sell 0 0 0 0
Mean Rec. 1.54 1.9 1.9 1.9